High-avidity anti-β2 glycoprotein I antibodies highly correlate with thrombosis in contrast to low-avidity anti-β2 glycoprotein I antibodies [2]

Journal of Thrombosis and Haemostasis

Volumn 4, Issue 7, 2006, Pages 1619-1621

  de Laat, B ^a   Derksen, R H W M ^a   de Groot, P G ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; BETA2 GLYCOPROTEIN 1; BETA2 GLYCOPROTEIN 1 ANTIBODY; IMMUNOGLOBULIN G; LUPUS ANTICOAGULANT; PHOSPHOLIPID ANTIBODY;

ANTIGEN BINDING; ANTIPHOSPHOLIPID SYNDROME; BINDING AFFINITY; BINDING ASSAY; BLOOD CLOTTING TEST; CLINICAL PRACTICE; CORRELATION ANALYSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; IMMUNOASSAY; IMMUNOREACTIVITY; LETTER; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SYSTEMIC LUPUS ERYTHEMATOSUS; THROMBOSIS;

ANTIBODY AFFINITY; ANTIPHOSPHOLIPID SYNDROME; AUTOANTIBODIES; BETA 2-GLYCOPROTEIN I; GLYCOPROTEINS; HUMANS; THROMBOSIS;

EID: 33745250488     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/j.1538-7836.2006.02002.x     Document Type: Letter

References (9)

1. Arnout J, Vermylen J. Current status and implications of autoimmune antiphospholipid antibodies in relation to thrombotic disease. J Thromb Haemost 2003; 1: 931-42.
2. Passam F, Krilis S. Laboratory tests for the antiphospholipid syndrome: current concepts. Pathology 2004; 36: 129 -38.
3. Reber G, Tincani A, Sanmarco M, de Moerloose P, Boffa MC, European Forum on Antiphospholipid Antibodies Standardization Group. Variability of anti-beta2 glycoprotein I antibodies measurement by commercial assays. Thromb Haemost 2005; 94: 665-72.
4. Kutteh WH, Franklin RD. Assessing the variation in antiphospholipid antibody (APA) assays: Comparison of results from 10 centers. Am J Obstet Gynecol 2004; 191: 440-8.
5. Favaloro EJ, Wong RC, Silvestrini R, McEvoy R, Jovanovich S, Roberts-Thomson P. A multilaboratory peer assessment quality assurance program-based evaluation of anticardiolipin antibody, and beta2-glycoprotein I antibody testing. Semin Thromb Hemost 2005; 31: 73-84.
6. Galli M, Luciani D, Bertolini G, Barbui T. Lupus anticoagulants are stronger risk factors for thrombosis than anticardiolipin antibodies in the antiphospholipid syndrome: A systematic review of the literature. Blood 2003; 101: 1827-32.
7. 2 -glycoprotein I dependent lupus anticoagulant highly correlates with thrombosis in the Antiphospholipid Syndrome. Blood 2004; 104: 3598-602.
8. Wilson WA, Gharavi AE, Koike T. International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: Report of an international workshop. Arthritis Rheum 1999; 42: 1309-11.
9. Miyakis S, Lockshin MD, Atsumi T, Branch DW, Brey RL, Cervera R, Derksen RHWM, de Groot PG, Koike T, Meroni PL, Reber G, Shoenfeld Y, Tincani A, Vlachoyiannopoulos PG, Krilis SA. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 2006; 4: 295-306.